| FSGEX | HSWSX | FSGEX / HSWSX | |
| Total Expense Ratio | 0.01 | 1.11 | 1% |
| Annual Report Gross Expense Ratio | 0.01 | 1.11 | 1% |
| Fund Existence | 17 years | 10 years | - |
| Gain YTD | 14.044 | 6.981 | 201% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 74.3B | 9.56B | 777% |
| Annual Yield % from dividends | 2.64 | 2.25 | 118% |
| Returns for 1 year | 28.94 | 14.20 | 204% |
| Returns for 3 years | 67.42 | 47.86 | 141% |
| Returns for 5 years | 50.82 | 34.80 | 146% |
| Returns for 10 years | 150.60 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ESAGX | 17.11 | 0.33 | +1.96% |
| Ashmore Emerging Markets Equity ESG A | |||
| VREQX | 11.86 | 0.12 | +1.02% |
| NYLI CBRE Real Estate Class R6 | |||
| AFVLX | 26.11 | 0.23 | +0.89% |
| Applied Finance Select Investor | |||
| MKVIX | 18.75 | 0.08 | +0.43% |
| MFS International Large Cap Value I | |||
| LGOAX | 51.59 | 0.08 | +0.16% |
| Patient Opportunity A | |||